Mestre L - Search Results

1

Chemical probes for the recognition of cannabinoid receptors in native systems.

Martín-Couce L, Martín-Fontecha M, Palomares O, Mestre L, Cordomí A, Hernangomez M, Palma S, Pardo L, Guaza C, López-Rodríguez ML, Ortega-Gutiérrez S. Martín-Couce L, et al. Among authors: mestre l. Angew Chem Int Ed Engl. 2012 Jul 9;51(28):6896-9. doi: 10.1002/anie.201200467. Epub 2012 Jun 11. Angew Chem Int Ed Engl. 2012. PMID: 22689411

2

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

Mestre L, Correa F, Arévalo-Martín A, Molina-Holgado E, Valenti M, Ortar G, Di Marzo V, Guaza C. Mestre L, et al. J Neurochem. 2005 Mar;92(6):1327-39. doi: 10.1111/j.1471-4159.2004.02979.x. J Neurochem. 2005. PMID: 15748152 Free article.

3

Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.

Correa F, Mestre L, Docagne F, Guaza C. Correa F, et al. Among authors: mestre l. Br J Pharmacol. 2005 Jun;145(4):441-8. doi: 10.1038/sj.bjp.0706215. Br J Pharmacol. 2005. PMID: 15821753 Free PMC article.

4

The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.

Correa F, Mestre L, Molina-Holgado E, Arévalo-Martín A, Docagne F, Romero E, Molina-Holgado F, Borrell J, Guaza C. Correa F, et al. Among authors: mestre l. Mini Rev Med Chem. 2005 Jul;5(7):671-5. doi: 10.2174/1389557054368790. Mini Rev Med Chem. 2005. PMID: 16026313 Review.

5

The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection.

Mestre L, Correa F, Docagne F, Clemente D, Guaza C. Mestre L, et al. Biochem Pharmacol. 2006 Sep 28;72(7):869-80. doi: 10.1016/j.bcp.2006.06.037. Epub 2006 Aug 17. Biochem Pharmacol. 2006. PMID: 16914119

6

[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].

Mestre L, Correa F, Docagne F, Clemente D, Ortega-Gutiérrez S, Arévalo-Martín A, Molina-Holgado E, Borrell J, Guaza C. Mestre L, et al. Rev Neurol. 2006 Nov 1-15;43(9):541-8. Rev Neurol. 2006. PMID: 17072810 Free article. Review. Spanish.

7

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.

Docagne F, Muñetón V, Clemente D, Ali C, Loría F, Correa F, Hernangómez M, Mestre L, Vivien D, Guaza C. Docagne F, et al. Among authors: mestre l. Mol Cell Neurosci. 2007 Apr;34(4):551-61. doi: 10.1016/j.mcn.2006.12.005. Epub 2007 Jan 16. Mol Cell Neurosci. 2007. PMID: 17229577

8

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

Correa F, Docagne F, Clemente D, Mestre L, Becker C, Guaza C. Correa F, et al. Among authors: mestre l. Biochem J. 2008 Feb 1;409(3):761-70. doi: 10.1042/BJ20071329. Biochem J. 2008. PMID: 17961121 Free article.

9

Cannabinoid system and neuroinflammation: implications for multiple sclerosis.

Correa F, Docagne F, Mestre L, Loría F, Hernangómez M, Borrell J, Guaza C. Correa F, et al. Among authors: mestre l. Neuroimmunomodulation. 2007;14(3-4):182-7. doi: 10.1159/000110644. Epub 2007 Dec 5. Neuroimmunomodulation. 2007. PMID: 18073512 Review.

10

Therapeutic potential of CB2 targeting in multiple sclerosis.

Docagne F, Mestre L, Loría F, Hernangómez M, Correa F, Guaza C. Docagne F, et al. Among authors: mestre l. Expert Opin Ther Targets. 2008 Feb;12(2):185-95. doi: 10.1517/14728222.12.2.185. Expert Opin Ther Targets. 2008. PMID: 18208367 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters